+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections



Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections



Journal of Hospital Infection 76(4): 324-327



The prevalence of urinary tract infections caused by fluoroquinolone-resistant Gram-negative bacilli (FQ-resistant GNB-UTIs) has been increasing. Previous studies that explored risk factors for FQ resistance have focused only on UTIs caused by Escherichia coli and/or failed to distinguish colonisation from infection. We conducted a case-control study at two medical centres within the University of Pennsylvania Health System to identify risk factors for FQ resistance among healthcare-acquired GNB-UTIs. Subjects with positive urine cultures for GNB and who met Centers for Disease Control and Prevention criteria for healthcare-acquired UTI were eligible. Cases were subjects with FQ-resistant GNB-UTI and controls were subjects with FQ-susceptible GNB-UTI matched to cases by month of isolation and species of infecting organism. In total, 251 cases and 263 controls were included from 1 January 2003 to 31 March 2005. Independent risk factors (adjusted odds ratio; 95% confidence interval) for FQ resistance included male sex (2.03; 1.21-3.39; P=0.007), African-American race (1.80; 1.10-2.94; P=0.020), chronic respiratory disease (2.58; 1.18-5.62; P=0.017), residence in a long term care facility (4.41; 1.79-10.88; P=0.001), hospitalisation within the past two weeks (2.19; 1.31-3.64; P=0.003), hospitalisation under a medical service (2.72; 1.63-4.54; P<0.001), recent FQ exposure (15.73; 6.15-40.26; P<0.001), recent cotrimoxazole exposure (2.49; 1.07-5.79; P=0.033), and recent metronidazole exposure (2.89; 1.48-5.65; P=0.002).

(PDF emailed within 0-6 h: $19.90)

Accession: 055581363

Download citation: RISBibTeXText

PMID: 20643497

DOI: 10.1016/j.jhin.2010.05.023


Related references

A clinical prediction rule for fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection. Infection Control and Hospital Epidemiology 32(11): 1124-1126, 2012

Gram-negative bacilli causing urinary tract infections. Indian Jour Microbiol 1(2): 103, 1961

Fluoroquinolone use and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2008. Journal of Infection 64(6): 618-620, 2012

Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations. Journal of ChemoTherapy 23(3): 171-174, 2011

Penicillinase producing gram negative bacilli as etiological factors of urinary tract infections. Antibiotiki 15(2): 102-107, 1970

Clinical studies on cross resistance of gram negative bacilli isolated from urinary tract infections against amino glycosides. Nishinihon Journal of Urology 41(6): 1069-1073, 1979

Fluoroquinolone use and resistance of Gram-positive bacteria causing healthcare-associated infections. Journal of Antimicrobial ChemoTherapy 67(6): 1560-1562, 2012

Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016-2017 update of the Chinese SMART study. Infection and Drug Resistance 12: 905-914, 2019

Molecular detection of ESBLs production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections. Indian Journal of Pathology and Microbiology 57(2): 244-248, 2015

Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001). Zhonghua Yi Xue Za Zhi 83(12): 1035-1045, 2003

Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrobial Agents and ChemoTherapy 60(4): 2265-2272, 2016

Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization. Clinical Microbiology and Infection 21(9): 843-849, 2016

Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients. Epidemiology and Infection 139(6): 955-961, 2011

Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections. Infection and Drug Resistance 12: 957-963, 2019

Gram-negative bacilli and chemotherapy in urinary tract infections. Iryo 20(11): 1141-1145, 1966